Target intelligence / Profile preview

General antioxidant pathways

Molecular classification
Enzyme [4], Transcription factor [6], Transporter [15], Other [13]
01

Overview

General antioxidant pathways encompass the complex network of endogenous enzymatic and non-enzymatic systems dedicated to maintaining cellular redox homeostasis [2, 4]. These pathways protect biological macromolecules from oxidative damage by neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated during normal metabolism or environmental stress [6, 16]. Key enzymatic components include superoxide dismutase (SOD), catalase, and the glutathione system, which are largely regulated by the transcription factor Nrf2 [4, 6]. In many chronic diseases, such as neurodegeneration, cardiovascular disorders, and cancer, an imbalance between ROS production and antioxidant capacity leads to pathological oxidative stress [5, 13, 16]. Pharmacological interventions target these pathways through Nrf2 activators, enzyme mimetics, or direct scavengers to restore balance [1, 3, 8]. However, the therapeutic use of antioxidants is complicated by the role of ROS as vital signaling molecules, meaning that excessive suppression can interfere with essential processes like immune response and cell signaling [14, 17].

Other names
Antioxidant defense system [13]Redox homeostasis pathways [6]Cellular antioxidant network [16]Endogenous antioxidant system [2]
02

Mechanism of action

Direct scavenging of reactive oxygen species [9]; activation of the Nrf2-ARE signaling pathway [6]; mimicking of endogenous antioxidant enzymes such as SOD and GPx [3]; chelation of redox-active metal ions [1]; and inhibition of pro-oxidant enzymes like NADPH oxidase and xanthine oxidase [8, 16].

03

Biological functions

Signal transduction [6]Apoptosis [12]Immune response [16]Cell proliferation [12]Cell death [3]Other [2]
04

Disease associations

Cancer [17]Inflammation [5]Neurodegenerative disease [6]Cardiovascular disease [11]Infection [5]Other [20]
05

Safety considerations

Disruption of physiological ROS signaling [14]Potential promotion of tumor growth and chemoresistance [17]Pro-oxidant activity at high doses [22]Poor bioavailability of exogenous antioxidants [4]
06

Interacting drugs

N-acetylcysteine [1]

10 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA) [19]8-hydroxy-2'-deoxyguanosine (8-OHdG) [10]Glutathione (GSH/GSSG) ratio [2]Superoxide dismutase (SOD) activity [4]Catalase activity [4]Protein carbonyls [10]4-hydroxynonenal (4-HNE) [19]

Beyond the preview

Go deeper on General antioxidant pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General antioxidant pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call